Trials / Completed
CompletedNCT00473057
Study of Autologous Stem Cell Transplantation for Patients With Ischemic Stroke
Phase I Study of Autologous Bone Marrow Cell Transplantation in Patient With Ischemic Stroke
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Universidade Federal do Rio de Janeiro · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This is a open label study to assess the safety of autologous bone marrow transplantation in patients with a ischemic stroke in the middle cerebral artery territory within 90 days from symptoms onset.
Detailed description
Objective: The purpose of this study is to evaluate the safety and feasibility of intra-arterial and intravenous injection of autologous bone marrow mononuclear cells in patients in the acute and sub-acute phase (\> 3 and \< 90 days after symptoms onset) of ischemic cerebral infarct in the middle cerebral artery territory. Methods: 15 patients with cerebral infarct within the middle cerebral artery territory will be enrolled in this prospective, nonrandomized, open-labeled study. Up to 10 patients will receive up to 500x 10 6 autologous bone marrow cells injected intra-arterially into the middle cerebral artery through percutaneous approach. The procedure is monitored by Transcranial Doppler (TCD) and electroencephalogram (EEG). Other 5 patients will receive up to 500x 10 6 autologous bone marrow cells injected intravenously. Changes in neurological deficits and improvements in functions will be evaluated at baseline and at regular intervals during follow-up ( 4 months). EEG and neuroimaging exams will be performed at baseline and at regular intervals during the follow-up period.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Autologous cell transplantation | Intra-arterial or intravenous delivery of autologous bone marrow cells |
Timeline
- Start date
- 2005-12-01
- Primary completion
- 2011-05-01
- Completion
- 2011-05-01
- First posted
- 2007-05-14
- Last updated
- 2011-05-19
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT00473057. Inclusion in this directory is not an endorsement.